We aim to be a company that specializes in the bio business, conducting research and possessing high-quality technology to contribute to the world.
Danaform Inc. aims to be a company that satisfies "customers," "shareholders," and "employees" as a brain trust with high research capabilities and quality technology, specializing in the bio business, and contributing to the world as a venture from RIKEN. We sell library preparation kits for the CAGE method as a new solution for gene expression analysis, and we conduct analysis from custom synthesis of libraries. Additionally, we also provide contract manufacturing of cDNA libraries with high full-length rates and low duplication rates. 【Business Activities】 ■ Gene expression analysis using CAGE method and NGS ■ Manufacturing and sales of nucleic acid detection-related products ■ Custom synthesis of fluorescent oligos ■ Distribution of various clones *For more details, please refer to our catalog or feel free to contact us.
Inquire About This Product
basic information
【Products and Services】 ■ CAGE kit sales ■ NGS sequencing outsourcing ■ CAGE analysis outsourcing service ■ nanoCAGE analysis outsourcing service ■ Full-length cDNA library synthesis outsourcing ■ Other library synthesis outsourcing ■ Bulk scale oligo synthesis outsourcing ■ Eprobe / Eprimer synthesis sales ■ Design and synthesis of double-labeled probes for qPCR ■ Clone search ■ FANTOM clones ■ Source BioScience products, etc. *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.
